Graham Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-22,304
| Closed | -$78.1K | – | 1161 |
|
|
2024
Q2 | $78.1K | Buy |
+22,304
| New | +$78.1K | ﹤0.01% | 936 |
|
|
2023
Q4 | – | Sell |
-146,872
| Closed | -$151K | – | 1112 |
|
|
2023
Q3 | $151K | Sell |
146,872
-22,276
| -13% | -$22.9K | ﹤0.01% | 886 |
|
|
2023
Q2 | $196K | Buy |
169,148
+144,142
| +576% | +$167K | 0.01% | 814 |
|
|
2023
Q1 | $37.8K | Buy |
+25,006
| New | +$37.8K | ﹤0.01% | 1000 |
|
|
2022
Q4 | – | Sell |
-890,650
| Closed | -$3.76M | – | 1149 |
|
|
2022
Q3 | $3.76M | Buy |
+890,650
| New | +$3.76M | 0.15% | 75 |
|